Coronavirus live updates: Covid-19 vaccination phase 2 to cover 60% of people
THE TIMES OF INDIA | Dec 08, 2020, 03:32:27 IST
Comments
Share
Coronavirus live updates: Covid-19 vaccination phase 2 to cover 60% of people
India's Covid-19 caseload rose to 96.44 lakh, while the total number of people who have recuperated from the disease crossed 91 lakh pushing the national recovery rate to 94.37 per cent, according to the Union Health Ministry data updated on Sunday. The Covid-19 active caseload plunged to almost 4 lakh after 138 days. Stay with TOI for latest updates:
With this, the weekly count of cases is now down by nearly two-thirds (62%) from its peak in September 6-13, with no signs yet of a second wave of the pandemic in the country. The death toll has shown no significant movement in the past four weeks and continues to hover around the 3,500 mark, with 3,539 fatalities recorded during the week (November 29-December 6). However, compared with the peak of 8,175 deaths recorded in September 13-20, Covid-related fatalities have dropped by 58%. There were 2,45,599 new cases reported this week, down from 2,91,903 last week (November 22-29).
China peddles falsehoods to obscure origin of Covid-19 pandemic (NYT)
The mild-mannered German scientist never anticipated becoming a Chinese propaganda star. But Alexander Kekulé, director of the Institute for Biosecurity Research in Halle, Germany, has been all over the state-run media in China in recent days. News outlets have taken Kekulé’s research out of context to suggest that Italy, not China, is where the coronavirus pandemic began. Photos of him have appeared on Chinese news sites under headlines reading, “China is innocent!” Kekulé, who has repeatedly said that he believes the virus first emerged in China, was startled. “This is pure propaganda,” he said in an interview.
08:41 (IST) Dec 07
Mizoram reported 2 new Covid-19 cases yesterday, reports ANI.
07:00 (IST) Dec 07
Sinovac secures $515 million to boost Covid-19 vaccine production
China's Sinovac Biotech SVA.O has secured $515 million in funding from a local firm to double production capacity of its coronavirus vaccine, the companies said on Monday, as it expects efficacy data of its experimental shot this month.
The Covid-19 death toll in Italy has exceeded 60,000, and 564 patients died over the past 24 hours, the country's health ministry said. A total of 60,078 people have died in Italy due to the coronavirus.
The government is expecting two vaccines against Covid-19 — Oxford-AstraZeneca’s Covishield and Bharat Biotech’s Covaxin — to be available by January and around four vaccines by the end of April, increasing the prospects of adequate supplies to inoculate some 30 crore priority population by July, an official said.
After staying around the same level for three weeks, fresh Covid-19 cases in India fell this week by around 16% from the previous seven days. With this, the weekly count of cases is now down by nearly two-thirds (62%) from its peak in September 6-13, with no signs yet of a second wave of the pandemic in the country.
Pfizer's Covid-19 shots could be shipped within 24 hours after Canadian approval
Shipment of Covid-19 vaccines in Canada could start within 24 hours after Canadian health authorities approve the shots, a top official of pharmaceutical company BioNTech told CBC on Sunday, comparing it with the timeline achieved in Britain.
A research by Northwestern Memorial Hospital, Chicago, has found that Covid-19 in some patients can lead to irreversible and permanent lung damage, rendering them irrecoverable, and leaving lung transplantation as the only option for survival. Meerut-born Dr Ankit Bharat, chief of thoracic surgery and surgical director of the lung transplant program at the hospital in Chicago, had also conducted the first lung transplant on a Covid-19 patient in the US in June 2020.
Uttar Pradesh's Gautam Buddh Nagar recorded 138 new Covid-19 cases that pushed the district's infection tally to 23,458 on Sunday, official data showed.
00:28 (IST) Dec 07
Around 19 patients from Max Life hospital in Ulhasnagar were shifted to other hospitals after a short circuit led to explosion in AC of the hospital. The hospital treats both Covid and non-Covid patients. All patients are stable.
The Serum Institute of India on Sunday became the first indigenous company to apply to the Drugs Controller General of India (DCGI) seeking emergency use authorisation for the Oxford Covid-19 vaccine in the country citing unmet medical needs due to the pandemic and in the interest of the public at large, official sources said.
India recorded 36,011 new Covid-19 infections in the last 24 hours, taking the total number of active coronavirus cases in the country to 4,03,248, said the Union ministry of health and family welfare on Sunday.
Serum Institute first Indian company to seek emergency use authorisation for Oxford Covid-19 vaccine Covishield in India, reports PTI
23:45 (IST) Dec 06
Some Covid patients face skin problems even after recovery, finds study
A new study suggests that some patients with Covid-19 have persistent skin-related symptoms long after they recover from the initial infection. The findings, presented at the 29th Congress of the European Academy of Dermatology and Venereology by investigators at Massachusetts General Hospital (MGH), point to another burden experienced by so-called "long haulers" who get better but don't seem to fully recover from Covid-19.